| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on July 18, 2006
Accepted on August 31, 2006
Department of Pediatrics (B.Y.B., C.J.K., W.L.M.), University of California, San Francisco, CA 94143; UCL Institute of Child Health & Department of Medicine (L.L., J.C.A.), University College London, London WC1N 1EH, UK; Endocrinology (J.R.), National Institute of Child Health, Karachi, Pakistan; Department of Paediatrics (C.P.S.), East Lancashire Hospitals NHS Trust, Blackburn BB2 3HH, UK
* To whom correspondence should be addressed. E-mail: j.achermann{at}ich.ucl.ac.uk.
Context: Congenital lipoid adrenal hyperplasia (lipoid CAH) is a severe disorder of adrenal and gonadal steroidogenesis caused by mutations in the steroidogenic acute regulatory protein (StAR). Affected children typically present with life-threatening adrenal insufficiency in early infancy due to a failure of glucocorticoid (cortisol) and mineralocorticoid (aldosterone) biosynthesis, and 46,XY genetic males have complete lack of androgenization and appear phenotypically female due to impaired testicular androgen secretion in utero. Objective: To investigate whether non-classic forms of this condition exist. Patients & Methods: Sequence analysis of the gene encoding StAR was undertaken in three children from two families who presented with primary adrenal insufficiency at 2-4 yr of age; the males had normal genital development. Identified mutants were tested in a series of biochemical assays. Results: DNA sequencing identified homozygous StAR mutations Val187Met and Arg188Cys in these two families. Functional studies of StAR activity in cells and in vitro, and cholesterol-binding assays showed these mutants retained
20% of wild-type activity. Conclusions: These patients define a new disorder, "non-classic lipoid CAH", and represent a new cause of non-autoimmune Addison disease (primary adrenal failure).
This article has been cited by other articles:
![]() |
C. J. Kim, L. Lin, N. Huang, C. A. Quigley, T. W. AvRuskin, J. C. Achermann, and W. L. Miller Severe Combined Adrenal and Gonadal Deficiency Caused by Novel Mutations in the Cholesterol Side Chain Cleavage Enzyme, P450scc J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 696 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, A. N. Urs, J. Allegood, A. Leon, A. H. Merrill Jr., and M. B. Sewer Cyclic AMP-Stimulated Interaction between Steroidogenic Factor 1 and Diacylglycerol Kinase {theta} Facilitates Induction of CYP17 Mol. Cell. Biol., October 1, 2007; 27(19): 6669 - 6685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abdulhadi-Atwan, A. Jean, W. K. Chung, K. Meir, Z. Ben Neriah, G. Stratigopoulos, S. E. Oberfield, I. Fennoy, H. J. Hirsch, A. Bhangoo, et al. Role of a Founder c.201_202delCT Mutation and New Phenotypic Features of Congenital Lipoid Adrenal Hyperplasia in Palestinians J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4000 - 4008. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Baker, R. F. Epand, R. M. Epand, and W. L. Miller Cholesterol Binding Does Not Predict Activity of the Steroidogenic Acute Regulatory Protein, StAR J. Biol. Chem., April 6, 2007; 282(14): 10223 - 10232. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |